These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26318388)

  • 21. Uric acid in heart failure: a biomarker or therapeutic target?
    Kaufman M; Guglin M
    Heart Fail Rev; 2013 Mar; 18(2):177-86. PubMed ID: 22584465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure.
    Bergamini C; Cicoira M; Rossi A; Vassanelli C
    Eur J Heart Fail; 2009 May; 11(5):444-52. PubMed ID: 19346534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xanthine oxidase activity affects pro-oxidative and pro-inflammatory profiles in spleen of silver catfish experimentally infected with Aeromonas caviae.
    Souza CF; Verdi CM; Baldissera MD; Doleski PH; Vizzotto BS; Santos RCV; Baldisserotto B
    Microb Pathog; 2017 Dec; 113():25-28. PubMed ID: 29042304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allopurinol or oxypurinol in heart failure therapy - a promising new development or end of story?
    Reyes AJ; Leary WP
    Cardiovasc Drugs Ther; 2005 Oct; 19(5):311-3. PubMed ID: 16382292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The physiology of endothelial xanthine oxidase: from urate catabolism to reperfusion injury to inflammatory signal transduction.
    Meneshian A; Bulkley GB
    Microcirculation; 2002 Jul; 9(3):161-75. PubMed ID: 12080414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Implications of Uric Acid in Heart Failure: A Comprehensive Review.
    Kumrić M; Borovac JA; Kurir TT; Božić J
    Life (Basel); 2021 Jan; 11(1):. PubMed ID: 33466609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds.
    Xu C; Wan X; Xu L; Weng H; Yan M; Miao M; Sun Y; Xu G; Dooley S; Li Y; Yu C
    J Hepatol; 2015 Jun; 62(6):1412-9. PubMed ID: 25623823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of urate and xanthine oxidase inhibitors in cardiovascular disease.
    George J; Struthers AD
    Cardiovasc Ther; 2008; 26(1):59-64. PubMed ID: 18466421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Weight Loss Mediated Reduction in Xanthine Oxidase Activity and Uric Acid Clearance in Adolescents with Severe Obesity.
    Tam HK; Kelly AS; Fox CK; Nathan BM; Johnson LA
    Child Obes; 2016 Aug; 12(4):286-91. PubMed ID: 26978590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Xanthine oxidase reaction with nitric oxide and peroxynitrite.
    Houston M; Chumley P; Radi R; Rubbo H; Freeman BA
    Arch Biochem Biophys; 1998 Jul; 355(1):1-8. PubMed ID: 9647660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma Xanthine Oxidase Activity Is Predictive of Cardiovascular Disease in Patients with Chronic Kidney Disease, Independently of Uric Acid Levels.
    Gondouin B; Jourde-Chiche N; Sallee M; Dou L; Cerini C; Loundou A; Morange S; Berland Y; Burtey S; Brunet P; Guieu R; Dussol B
    Nephron; 2015; 131(3):167-74. PubMed ID: 26426087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes in xanthine oxidase activity in patients with circulatory failure].
    Bakhtiiarov ZA
    Ter Arkh; 1989; 61(5):68-9. PubMed ID: 2781495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allopurinol as a cardiovascular drug.
    Kelkar A; Kuo A; Frishman WH
    Cardiol Rev; 2011; 19(6):265-71. PubMed ID: 21983313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study).
    Kojima S; Sakamoto T; Ishihara M; Kimura K; Miyazaki S; Yamagishi M; Tei C; Hiraoka H; Sonoda M; Tsuchihashi K; Shimoyama N; Honda T; Ogata Y; Matsui K; Ogawa H;
    Am J Cardiol; 2005 Aug; 96(4):489-95. PubMed ID: 16098298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sleeve gastrectomy reduces xanthine oxidase and uric acid in a rat model of morbid obesity.
    Oberbach A; Neuhaus J; Schlichting N; Kugler J; Baumann S; Till H
    Surg Obes Relat Dis; 2014; 10(4):684-90. PubMed ID: 24583053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model.
    Nakatsu Y; Seno Y; Kushiyama A; Sakoda H; Fujishiro M; Katasako A; Mori K; Matsunaga Y; Fukushima T; Kanaoka R; Yamamotoya T; Kamata H; Asano T
    Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G42-51. PubMed ID: 25999428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transient reduction in myocardial free oxygen radical levels is involved in the improved cardiac function and structure after long-term allopurinol treatment initiated in established chronic heart failure.
    Mellin V; Isabelle M; Oudot A; Vergely-Vandriesse C; Monteil C; Di Meglio B; Henry JP; Dautreaux B; Rochette L; Thuillez C; Mulder P
    Eur Heart J; 2005 Aug; 26(15):1544-50. PubMed ID: 15872033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Xanthine Oxidase Induces Foam Cell Formation through LOX-1 and NLRP3 Activation.
    Dai Y; Cao Y; Zhang Z; Vallurupalli S; Mehta JL
    Cardiovasc Drugs Ther; 2017 Feb; 31(1):19-27. PubMed ID: 28084571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperuricaemia and congestive heart failure: causation or association?
    Gottlieb S
    Eur Heart J; 1998 Dec; 19(12):1746-7. PubMed ID: 9886713
    [No Abstract]   [Full Text] [Related]  

  • 40. [Xanthine dehydrogenase (xanthine oxidase)].
    Ichida K; Yamaguchi Y; Matsumura T
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():98-102. PubMed ID: 12629699
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.